Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Guilhaumou

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Therapie|January 11, 2021
Towards personalized pharmacology: Antipsychotics and schizophreniaLouise Carton, Régis Bordet, François Montastruc, et al.
Clinical Pharmacokinetics|June 22, 2016
Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic StudiesAmélie Marsot, Romain Guilhaumou, Camille Riff, et al.
Therapie|June 9, 2023
Cannabidiol and pharmacokinetics drug-drug interactions: Pharmacological toolboxClémence Lacroix, Romain Guilhaumou, Joëlle Micallef, et al.
Clinical Pharmacokinetics|March 28, 2022
Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult PatientsIbrahim El-Haffaf, Romain Guilhaumou, Lionel Velly, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|July 19, 2017
Levodopa in Parkinson's Disease: A Review of Population Pharmacokinetics/Pharmacodynamics AnalysisAmélie Marsot, Romain Guilhaumou, Jean Philippe Azulay, et al.
British Journal of Clinical Pharmacology|November 29, 2022
Impact of piperacillin unbound fraction variability on dosing recommendations in critically ill patientsIbrahim El-Haffaf, Romain Guilhaumou, Lionel Velly, et al.
Pharmacology & Therapeutics|July 14, 2020
Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatmentFrançoise Stanke-Labesque, Elodie Gautier-Veyret, Stephanie Chhun, et al.
Biomedical Chromatography : BMC|July 16, 2016
Simultaneous determination of four antiepileptic drugs in human plasma samples using an ultra-high-performance liquid chromatography tandem mass spectrometry method and its application in therapeutic drug monitoringJulien Dupouey, Natalia Doudka, Séphora Belo, et al.
Therapie|May 21, 2016
[Potentially toxic antibiotics concentrations after administration using impregnated dressing in a severe burned patient: A case report]Julien Dupouey, Sandrine Wiramus, Jacques Albanese, et al.
Fundamental & Clinical Pharmacology|December 18, 2009
Effects of induced hyperthermia on pharmacokinetics of ropivacaine in ratsRomain Guilhaumou, Audrey Boulamery, Bénédicte Deluca, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Therapie|January 11, 2021
Towards personalized pharmacology: Antipsychotics and schizophreniaLouise Carton, Régis Bordet, François Montastruc, et al.
Clinical Pharmacokinetics|June 22, 2016
Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic StudiesAmélie Marsot, Romain Guilhaumou, Camille Riff, et al.
Therapie|June 9, 2023
Cannabidiol and pharmacokinetics drug-drug interactions: Pharmacological toolboxClémence Lacroix, Romain Guilhaumou, Joëlle Micallef, et al.
Clinical Pharmacokinetics|March 28, 2022
Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult PatientsIbrahim El-Haffaf, Romain Guilhaumou, Lionel Velly, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|July 19, 2017
Levodopa in Parkinson's Disease: A Review of Population Pharmacokinetics/Pharmacodynamics AnalysisAmélie Marsot, Romain Guilhaumou, Jean Philippe Azulay, et al.
British Journal of Clinical Pharmacology|November 29, 2022
Impact of piperacillin unbound fraction variability on dosing recommendations in critically ill patientsIbrahim El-Haffaf, Romain Guilhaumou, Lionel Velly, et al.
Pharmacology & Therapeutics|July 14, 2020
Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatmentFrançoise Stanke-Labesque, Elodie Gautier-Veyret, Stephanie Chhun, et al.
Biomedical Chromatography : BMC|July 16, 2016
Simultaneous determination of four antiepileptic drugs in human plasma samples using an ultra-high-performance liquid chromatography tandem mass spectrometry method and its application in therapeutic drug monitoringJulien Dupouey, Natalia Doudka, Séphora Belo, et al.
Therapie|May 21, 2016
[Potentially toxic antibiotics concentrations after administration using impregnated dressing in a severe burned patient: A case report]Julien Dupouey, Sandrine Wiramus, Jacques Albanese, et al.
Fundamental & Clinical Pharmacology|December 18, 2009
Effects of induced hyperthermia on pharmacokinetics of ropivacaine in ratsRomain Guilhaumou, Audrey Boulamery, Bénédicte Deluca, et al.
Pageof 6